Acorns Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Acorns Advisers's LLY Position: Q1 2026 in Review
Acorns Advisers increased its Eli Lilly (LLY) stake by 16% in Q1 2026, buying an estimated $321K and bringing the position to 2,296 shares worth $2.11M. The position accounts for 0.02% of the portfolio, ranked #37.
Acorns Advisers first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.13M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Acorns Advisers held 2,296 shares of Eli Lilly worth $2.11M as of Q1 2026.
- Acorns Advisers bought 317 Eli Lilly shares in Q1 2026, an estimated $321K.
- Eli Lilly made up 0.02% of Acorns Advisers's portfolio in Q1 2026, its #37 holding.
- Acorns Advisers first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
- Acorns Advisers's Eli Lilly position peaked at $2.13M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Acorns Advisers's 13F filing for Q1 2026, filed 14 May 2026.